Skip to main content
Premium Trial:

Request an Annual Quote

GE Expands Rights to Use, Sublicense Fisher BioImage's Green Fluorescent Protein


NEW YORK (GenomeWeb News) - GE Healthcare has obtained a license to use Fisher BioImage’s green fluorescent protein technology beyond life science research, GE said today.
 
The expanded licensing agreement expands GE's rights to develop and sell products using this technology and gives it the right to sublicense the IP.
 
Financial terms of the deal were not announced.
 
GFP is a fluorescent protein from the jellyfish Aequorea victoria and is applied in many areas of drug discovery and veterinary and plant science research.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.